Related Experiment Video
Updated: Dec 24, 2025

10:58
Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
Published on: September 27, 2020
5.4K
RNA interference as a therapeutic strategy for treating CNS disorders.
1Novartis Institutes for BioMedical Research (NIBR), Neuroscience Research, WSJ 386-745, CH-4002 Basel, Switzerland.
Drug Discovery Today. Therapeutic Strategies
|April 15, 2020
Summary
RNA interference (RNAi) offers a precise method for gene silencing, enabling targeted treatment for various diseases. Pharmaceutical companies are exploring RNAi therapies for neuropsychiatric and other conditions.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- RNA interference (RNAi) is a natural gene silencing mechanism.
- RNAi's potential for targeted gene regulation is significant.
- Advancements in siRNA and shRNA design have improved efficacy.
Purpose of the Study:
- To highlight recent findings in RNAi technology.
- To discuss the pharmaceutical industry's application of RNAi.
- To explore RNAi's use in treating neuropsychiatric and other diseases.
Main Methods:
- Review of recent scientific literature on RNAi.
- Analysis of pharmaceutical industry strategies for RNAi development.
- Focus on small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs).
Main Results:
- RNAi demonstrates high selectivity in targeting disease-related genes.
- RNAi effectively downregulates gene expression both in vitro and in vivo.
- Progress in modeling and chemistry has made siRNA/shRNA design routine.
Conclusions:
- RNAi is a powerful tool for gene silencing with broad therapeutic potential.
- The pharmaceutical industry is actively pursuing RNAi-based treatments.
- RNAi holds promise for treating complex diseases, including neurological disorders.
Related Concept Videos
siRNA - Small Interfering RNAs
18.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
RNA Interference
27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K

